ArticleScience advances2020

Sustained release of a GLP-1 and FGF21 dual agonist from an injectable depot protects mice from obesity and hyperglycemia.

C A Gilroy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.